Superworth

Tempest Therapeutics market cap TPST

Share price times shares outstanding: what the whole company sells for, since 2012.

Today, Oct 23, 2026
$7.6M
Highest close in our data
$1.3B
Mar 2015

Tempest Therapeutics is worth $7.6M at the close on Oct 23, 2026, at $0.51 a share.

That is down 84% over the last year and down 90% over five years.

Its highest close in our data was $1.3B in Mar 2015.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$7.6M$7.6M$29.4M−43%
2025$13.3M$13.3M$48.8M−64%
2024$36.7M$22.9M$86.8M−57%
2023$84.7M$3.4M$84.7M+600%
2022$12.1M$12.1M$37M−67%
2021$36.5M$14.2M$101.4M−10%
2020$40.7M$21.7M$134.3M−56%
2019$92.6M$20.5M$228.4M+427%
2018$17.6M$17.6M$45.3M−65%
2017$50M$46M$66.6M−8%
2016$54.5M$49.8M$304.8M−80%
2015$266.4M$257.4M$1.3B−76%
2014$1.1B$134.5M$1.2B+561%
2013$166M$119.7M$254.6M+37%
2012$121.2M$114M$130.4Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Tempest Therapeutics' size, closest first, today.

CompanyMarket cap
TPSTTempest Therapeutics$7.6M
ATNMActinium Pharmaceuticals$47.8M
SPROSpero Therapeutics$64.6M
LFVNLifevantage$73.4M
Peer median$64.6M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Tempest Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.